Skip to main content

Table 1 Sample information

From: Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17-producing CD8+ T cells in nasopharyngeal carcinoma

No. Gender Age (yr) Histological typea WHO classificationb Clinical stage
NPC1 F 52 III T3N1M0 III
NPC2 M 29 III T2N2M0 III
NPC3 M 53 III T3N0M0 III
NPC4 M 45 III T4N2M0 IVA
NPC5 M 46 III T4N1M0 IVA
NPC6 M 47 III T2N0M0 II
NPC7 M 63 III T4N2M0 IVA
NPC8 M 36 III T3N1M0 III
NPC9 M 44 III T3N1M0 III
NPC10 F 29 III T2N2M0 III
NPC11 M 38 III T2N2M0 III
NPC12 F 31 III T3N2M0 III
NPC13 M 39 III T3N2M0 III
NPC14 F 25 III T3N1M0 III
NPC15 M 38 III T3N2M0 III
NPC16 M 34 III T3N1M0 III
NPC17 M 38 III T3N2M0 III
NPC18 M 42 III T3N1M0 III
NPC19 M 30 III T3N2M1 IVA
NPC20 M 54 III T2N1M0 II
NPC21 M 56 III T2N2M0 IVA
  1. aHistological type: I = differentiated keratinizing squamous cell carcinoma; II = differentiated nonkeratinizing carcinoma; III = undifferentiated carcinoma. bTNM stage according to WHO UICC-AJCC 1997 standards (International Union Against Cancer/American Joint Committee on Cancer)